Bristol-Myers Squibb buy Truist Financial Co.
Start price
15.09.23
/
50%
€55.60
Target price
15.09.24
€78.67
Performance (%)
-20.88%
End price
16.09.24
€43.99
Summary
This prediction ended on 16.09.24 with a price of €43.99. The price of Bristol-Myers Squibb has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -20.88%. Truist_Financial_Co_ has a follow-up prediction for Bristol-Myers Squibb where he still thinks Bristol-Myers Squibb is a Buy. Dividends of €2.19 are taken into consideration when calculating the performance. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Bristol-Myers Squibb | -1.218% | -1.218% | 43.789% |
| iShares Core DAX® | 2.573% | 3.502% | 8.408% |
| iShares Nasdaq 100 | 4.858% | 0.654% | 28.383% |
| iShares Nikkei 225® | 5.590% | -0.246% | 52.915% |
| iShares S&P 500 | 3.250% | 2.083% | 24.370% |
Comments by Truist_Financial_Co_ for this prediction
In the thread Bristol-Myers Squibb diskutieren
Bristol-Myers Squibb (NYSE: BMY) had its "buy" rating re-affirmed by analysts at Truist Financial Co.. They now have a $84.00 price target on the stock.
Ratings data for BMY provided by MarketBeat
In the thread Trading Bristol-Myers Squibb
Die von Truist_Financial_Co_ gewählte maximale Laufzeit wurde überschritten
Current prediction by Truist_Financial_Co_ for Bristol-Myers Squibb
Bristol-Myers Squibb
Start price
Target price
Perf. (%)
€56.71
31.07.26
31.07.26
€60.82
31.07.27
31.07.27
-1.30%
07.08.26
07.08.26
Stopped prediction by Truist_Financial_Co_ for Bristol-Myers Squibb
Bristol-Myers Squibb
Start price
Target price
Perf. (%)
€55.56
08.01.25
08.01.25
€63.06
08.01.26
08.01.26
-13.17%
09.01.26
09.01.26
Bristol-Myers Squibb
Start price
Target price
Perf. (%)
€53.50
06.10.23
06.10.23
€79.27
06.10.24
06.10.24
-8.08%
07.10.24
07.10.24